tiprankstipranks
Trending News
More News >
Standex International (SXI)
NYSE:SXI
Advertisement

Standex International (SXI) AI Stock Analysis

Compare
78 Followers

Top Page

SXI

Standex International

(NYSE:SXI)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 4o)
Rating:73Outperform
Price Target:
$252.00
▲(3.86% Upside)
Standex International's overall stock score is driven by strong earnings call guidance and positive technical indicators, suggesting future growth potential. However, the high P/E ratio and reduced cash flow pose valuation concerns. Financial performance is solid but requires attention to leverage and net income challenges.
Positive Factors
Revenue Growth
Strong sales growth indicates effective market expansion and product demand, supporting long-term revenue stability and business scalability.
New Product Development
Continuous product innovation enhances competitive positioning and market relevance, driving sustained growth and customer engagement.
Debt Reduction
Lowering debt levels improves financial flexibility and reduces risk, enabling strategic investments and operational resilience.
Negative Factors
Organic Revenue Decline
Declining organic revenue suggests challenges in core market demand, potentially impacting long-term growth if not addressed.
Challenges in Scientific Segment
Weakness in the Scientific segment, driven by external funding cuts, could hinder growth and require strategic adjustments.
Tariff and Trade Uncertainties
Tariff uncertainties pose cost challenges, potentially affecting margins and competitiveness, necessitating strategic sourcing adjustments.

Standex International (SXI) vs. SPDR S&P 500 ETF (SPY)

Standex International Business Overview & Revenue Model

Company DescriptionStandex International Corporation, together with subsidiaries, manufactures and sells various products and services for commercial and industrial markets in the United States and internationally. It operates through five segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The Electronics segment offers reed relays, fluid level, proximity, motion, flow, HVAC condensate, and custom electronics sensors; and current sense and advanced planar transformer technologies, value added assemblies, and mechanical packaging, as well as custom wound transformers and inductors for low and high frequency applications. The Engraving segment provides mold texturizing, slush molding tools, roll engraving, hygiene product tooling, and low observation vents, as well as project management and design services for stealth aircraft; and process machinery for various industries. The Scientific segment offers temperature controlled equipment for the medical, scientific, pharmaceutical, biotech, and industrial markets. The Engineering Technologies segment offers net and near net formed single-source customized solutions that are used in the manufacture of engineered components for the aviation, aerospace, defense, energy, industrial, medical, marine, oil and gas, and manned and unmanned space markets. The Specialty Solutions segment manufactures and sells refrigerated, heated and dry merchandizing display cases, custom fluid pump solutions, single and double acting telescopic, and piston rod hydraulic cylinders. Standex International Corporation was founded in 1955 and is headquartered in Salem, New Hampshire.
How the Company Makes MoneyStandex International generates revenue through the sale of its diverse product offerings across its various business segments. The Food Service Equipment division is a significant contributor, providing solutions for commercial kitchens and food preparation, which includes cooking equipment and refrigeration systems. The Engineering Technologies segment focuses on custom-engineered products that cater to specific industrial needs, while the Electronics division manufactures components used in various electronic applications. The Hydraulics segment offers hydraulic solutions that serve both industrial and mobile markets. Standex also benefits from strategic partnerships with key players in its target industries, enhancing its market reach and enabling collaborative product development. Additionally, the company's commitment to research and development ensures a continuous stream of innovative products, further driving sales and revenue growth.

Standex International Earnings Call Summary

Earnings Call Date:Jul 31, 2025
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Oct 30, 2025
Earnings Call Sentiment Positive
Standex delivered a strong performance in fiscal 2025 with record profit generation, significant sales growth from acquisitions, and improved operating margins. However, challenges remain with organic revenue declines and softness in certain segments, particularly in the Specialty Solutions and Scientific segments. Overall, the positive aspects of growth in fast growth markets and new products outweigh the lowlights.
Q4-2025 Updates
Positive Updates
Record Profit Generation in Fiscal 2025
Standex achieved a record profit generation in fiscal 2025, with significant contributions from recent acquisitions and growth in fast growth markets.
Strong Fourth Quarter Sales Increase
Fourth quarter sales increased by 23.2%, driven by acquisitions and a slight organic decline. Electronics grew slightly on an organic basis with a book-to-bill ratio above 1 and organic orders up 16% year-on-year.
Expansion into Fast Growth Markets
Sales into fast growth markets increased to 28% of total company sales in the fourth quarter, with expectations to grow by approximately 45% year-on-year in fiscal 2026, exceeding $265 million.
Record Adjusted Operating Margin Achievement
Standex achieved a record adjusted operating margin of 20.6% in the fourth quarter, up 350 basis points year-on-year.
Growth Through New Products and Acquisitions
New product sales added approximately 2.8% to sales, and the company released 16 new products in fiscal 2025, with plans to release more than 15 new products in fiscal 2026.
Negative Updates
Organic Revenue Decline
There was an organic revenue decline of 1.4% in the fourth quarter, partially offsetting the benefits from acquisitions and foreign currency.
Scientific Segment Organic Decline
Scientific revenue saw an organic decline of 13.9% due to lower demand from academic and research institutions impacted by NIH funding cuts.
Challenges in Specialty Solutions Segment
Specialty Solutions segment revenue decreased by 1.2% year-on-year, primarily due to general market softness, and operating margin decreased by 360 basis points.
Company Guidance
During the Standex International Fiscal Fourth Quarter 2025 Financial Results Conference Call, the company provided robust guidance for the upcoming fiscal year, highlighting several key metrics. Standex reported a 23.2% year-on-year increase in total revenue for Q4 2025, reaching $222 million, with an adjusted operating margin rising by 350 basis points to a record 20.6%. For fiscal year 2026, Standex anticipates over $100 million in revenue growth, driven by mid- to high single-digit organic growth in Electronics and double-digit growth in Engineering Technologies. The company plans to release more than 15 new products, contributing approximately 300 basis points to sales growth, and expects fast growth market sales to rise by about 45% to over $265 million. Standex aims to reduce its net leverage ratio to 2.0x by the end of fiscal 2026, following a decrease to 2.6x in Q4 2025. The company is also targeting significant long-term growth, with goals of achieving sales exceeding $1.15 billion and an adjusted operating margin greater than 23% by fiscal year 2028.

Standex International Financial Statement Overview

Summary
Standex International demonstrates robust revenue growth and improved operational margins, yet faces challenges with net income reduction and higher leverage. While cash flow has decreased, the company's investment activities may position it well for future opportunities. Overall, the financials show strong performance with some areas needing attention.
Income Statement
75
Positive
The income statement shows strong growth, with a notable revenue increase from $720.6M to $790.1M (9.6% growth). Gross profit margin improved to 38.0%, and EBIT margin increased to 15.4%, indicating enhanced profitability. However, net income decreased to $55.8M, lowering the net profit margin to 7.1%. Despite this, the company maintains solid operational efficiency.
Balance Sheet
70
Positive
The balance sheet reflects a stable financial position with an equity ratio of 45.4%, indicating solid equity backing. The debt-to-equity ratio increased to 0.83, suggesting higher leverage, which could pose a risk if not managed well. However, return on equity remains healthy at 7.8%, showing effective use of equity.
Cash Flow
65
Positive
Cash flow analysis reveals a decrease in free cash flow from $72.4M to $41.3M, indicating a decline in cash generation capacity. The operating cash flow to net income ratio is 1.25, suggesting decent cash conversion. While free cash flow decreased, the company made substantial investments that could drive future growth.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue790.11M790.11M720.63M741.05M735.34M656.23M
Gross Profit310.60M300.64M282.00M285.10M269.95M241.26M
EBITDA118.75M128.18M121.92M191.45M116.63M91.98M
Net Income55.76M55.76M73.07M138.99M61.39M36.47M
Balance Sheet
Total Assets1.57B1.57B1.01B1.02B934.44M962.22M
Cash, Cash Equivalents and Short-Term Investments104.54M104.54M154.20M195.71M104.84M136.37M
Total Debt603.70M592.57M187.89M199.22M214.08M228.53M
Total Liabilities827.29M827.29M383.55M417.48M435.10M455.80M
Stockholders Equity711.68M711.68M621.50M607.45M499.34M506.43M
Cash Flow
Free Cash Flow61.06M41.25M72.36M66.53M53.83M61.83M
Operating Cash Flow69.64M69.60M92.66M90.80M77.72M83.58M
Investing Cash Flow-503.43M-503.43M-61.63M41.56M-31.04M-39.09M
Financing Cash Flow380.49M380.49M-69.20M-40.04M-69.43M-31.73M

Standex International Technical Analysis

Technical Analysis Sentiment
Positive
Last Price242.63
Price Trends
50DMA
214.85
Positive
100DMA
191.41
Positive
200DMA
178.82
Positive
Market Momentum
MACD
9.06
Negative
RSI
66.82
Neutral
STOCH
76.89
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SXI, the sentiment is Positive. The current price of 242.63 is above the 20-day moving average (MA) of 228.19, above the 50-day MA of 214.85, and above the 200-day MA of 178.82, indicating a bullish trend. The MACD of 9.06 indicates Negative momentum. The RSI at 66.82 is Neutral, neither overbought nor oversold. The STOCH value of 76.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SXI.

Standex International Risk Analysis

Standex International disclosed 26 risk factors in its most recent earnings report. Standex International reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Standex International Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
$2.20B24.4322.47%0.10%4.65%8.81%
$2.93B52.298.37%0.52%9.64%-24.68%
$1.91B54.903.93%0.63%-5.41%17.47%
$10.79B15.437.44%2.01%2.89%-14.66%
$2.22B-1.50%2.87%-7.93%91.44%
$2.53B-21.02%20.19%-12.34%
$1.88B-2.22-28.31%14.40%-662.25%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SXI
Standex International
242.63
54.72
29.12%
EPAC
Enerpac Tool Group
41.59
-2.28
-5.20%
ENOV
Enovis
32.86
-9.20
-21.87%
HI
Hillenbrand
31.51
4.65
17.31%
HLIO
Helios Technologies
57.54
10.95
23.50%
XMTR
Xometry
49.39
29.78
151.86%

Standex International Corporate Events

Standex International Reports Strong FY25 Financial Results
Aug 2, 2025

Standex International Corporation is a diversified multi-industry manufacturer operating in five sectors: Electronics, Engineering Technologies, Scientific, Engraving, and Specialty Solutions, with a global presence in countries such as the United States, Europe, and China.

Standex International’s Earnings Call Highlights Growth and Challenges
Aug 2, 2025

Standex International’s latest earnings call painted a picture of both achievement and challenge. The company celebrated significant milestones in profit generation, segment growth, and new product development, setting a positive tone for fiscal 2026. However, the discussion also acknowledged hurdles such as a decline in organic revenue, difficulties within the Scientific segment, and pressures from debt, which tempered the overall optimism.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 14, 2025